Central regions | Technology & innovation

Technology for third-generation flu vaccine developed in Russia

10 Sep '14
Russian scientists have created a new technology to develop a flu vaccine. The word came from Moscows NPO Microgen, a national leader in immunological solutions development and the developer of the new drug candidate.

According to Microgen, with the new technology the vaccine maker wont need adjuvants, special immunological agents that are added to a vaccine to get the immune system to produce a higher amount of antibodies. The new approach also makes sure a patient receives cross-protection even against the flu strains which the vaccine doesnt contain.

The invention, for which we have obtained a patent, will enable us to produce a flu vaccine as efficient as possible. This is a third-generation vaccine, Microgen CEO Petr Kanygin said.

The vaccine will hit the market in 2016, Microgen hopes.
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
COMMENT ON THIS STORY
Find Related Content

Locations: Moscow

Latest News: Central regions
24 May '18 | Finance, business | Technology & innovation
23 May '18 | Retail, FMCG | Finance, business
21 May '18 | Finance, business | Technology & innovation
16 May '18 | Finance, business | Technology & innovation
 

Feature stories

3 Apr '18
In regions most of European Russians will hardly ever...
21 Nov '17
Russian scientists have come up with what they say is...
7 Sep '17
Search (News archive - 21240)
Advertising
RB_Partners_Report
Advertising
gcvsymposium
Advertising
Independent Software Developers Forum
Advertising
Marchmont News

Latest News

24 May '18
BKS, a Russian company, and its partners have...
23 May '18
A U.S.-based start-up of Russian origin, Scentbird,...
22 May '18
Severstal, one of Russias largest mining and...

Most read stories from last week

22 May '18
Severstal, one of Russias largest mining and...
23 May '18
A U.S.-based start-up of Russian origin, Scentbird,...
24 May '18
BKS, a Russian company, and its partners have...